GYRE THERAPEUTICS, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net income from operations ($21.6m) ($30.1m) ($55.2m) ($56.2m) ($87.9m) ($8.2m) ($85.5m) $17.9m $9.9m
Net Income (Loss) Attributable to Parent ($16.9m) ($21.6m) ($30.1m) ($55.2m) ($56.2m) ($87.9m) ($8.2m) ($85.5m) $17.9m $9.9m
Net Income (Loss) Available to Common Stockholders, Basic ($25.5m) ($30.1m) ($55.2m) ($56.2m) ($92.9m) $12.1m $5.0m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest ($30.1m) ($55.2m) ($56.2m) ($87.9m) ($8.2m) ($85.5m) $17.9m $9.9m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest ($85.5m) $17.9m $9.9m
Net Income (Loss) Attributable to Noncontrolling Interest $7.5m $5.8m $4.9m
Depreciation, Depletion and Amortization $389k $173k $149k $146k $138k $290k $230k $1.1m $1.5m $2.5m
Depreciation $400k $200k $100k $146k $138k $290k $230k $1.0m $1.3m $2.0m
Amortization of Debt Issuance Costs $9k
Amortization of Intangible Assets $100k $38k $576k
Amortization of land use rights $42k $40k $39k $39k
Deferred Income Tax Expense (Benefit) ($834k) ($1.0m) ($1.1m)
Deferred income taxes, net ($838k) ($1.2m) ($1.0m) ($1.1m)
Share-based Payment Arrangement, Noncash Expense $635k $863k $2.6m $3.2m $3.6m $3.4m $1.3m $7.3m $831k $7.2m
Share-based Payment Arrangement, Expense $635k $863k $2.6m $3.2m $3.6m $3.4m $1.3m $7.3m $831k $7.2m
Equity Method Investment, Other than Temporary Impairment ($1.3m) ($1.0m) $0 $0
Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property $600k $0 ($116k) $498k $628k $66k $4k
Gain (Loss) on Disposition of Assets $1.7m ($18k) $57.2m ($4k)
Gain (Loss) on Disposition of Business ($2.7m)
Gain (Loss) on Disposition of Property Plant Equipment $557k $0 ($116k) $498k ($628k) ($66k) ($4k)
Gain (Loss) on Extinguishment of Debt $99k $0
Income Tax Expense (Benefit) $348k $8.5m $5.3m $4.6m
Operating Lease, Expense $600k $700k $1.7m $1.7m $500k $700k $900k
Other Nonoperating Income (Expense) $86k $261k $1.6m ($39k) $659k ($87k) ($1.7m) ($1.5m)
Operating lease liabilities ($429k) ($473k) ($816k) ($744k)
Purchase of equity method investment ($1.3m) ($1.0m) ($1.7m)
Right-of-use asset obtained in exchange for operating lease liabilities $57k $277k $2.0m $63k
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($461k) ($7k) $15.0m ($11.7m) ($1.5m) $5.3m $10.8m
Increase (Decrease) in Inventories ($1.7m) $2.1m $3.6m
Increase (Decrease) in Accounts Payable ($102k) ($90k) $500k $3.0m $1.7m $500k ($6.2m) $192k ($245k) $13k
Proceeds from Stock Options Exercised $0 $1.9m $2.4m
Debt Securities, Available-for-sale, Realized Gain (Loss) $0
General and Administrative Expense $9.3m $10.0m $12.4m $13.4m $16.2m $19.0m $17.4m $14.7m $16.1m $20.8m
Operating Expenses $20.8m $22.8m $33.8m $57.3m $78.3m $95.2m $9.4m $176.0m $85.7m $105.1m
Payments of Financing Costs $1.5m
Revenue from Contract with Customer, Including Assessed Tax $113.5m $105.8m
Stock-based compensation $635k $863k $2.6m $3.2m $3.6m $3.4m $1.3m $7.3m $831k $7.2m
Noncash lease expense $404k $355k $672k $777k
Bad debt expense and other non-cash items $22k ($61k) $170k ($63k)
Accrued interest on bank deposit ($633k) ($1.0m) $28k
Change in fair value of receivables from GCBP ($39k) $239k ($39k)
Change in fair value of derivative liabilities $39k $239k $39k
Change in fair value of warrant liability $9.3m ($7.2m) ($2.7m)
Equity loss of unconsolidated affiliates $251k $1.3m $37k $77k
Notes receivable $1.1m ($4.0m) ($1.1m)
Accounts receivable $461k $7k ($15.0m) $11.7m $1.5m $285k ($5.3m) ($10.8m)
Inventories ($879k) $1.7m ($2.1m) ($3.6m)
Prepaid and other assets $956k ($351k) ($2.9m) ($490k) ($3.0m) $3.9m $1.6m ($82k) $520k ($206k)
Income tax payable ($1.3m) $3.0m ($2.2m) $44k
Accounts payable ($102k) ($90k) $500k $3.0m $1.7m $500k ($6.2m) $192k ($245k) $13k
Other noncurrent liabilities ($102k) $23k ($47k)
Due to related parties $425k ($83k) ($1k)
Accrued expenses and other liabilities $1.9m $1.4m ($1.5m) $946k
Acquisition of intangible assets ($13k) ($69k) ($813k) ($733k)
Purchase of certificates of deposit ($7.5m) ($15.7m) ($15.5m) ($14.0m)
Proceeds from sale of equipment $1.7m $664k $401k $30k
Offering costs paid ($536k) ($1.5m)
Proceeds from the exercise of stock options $0 $1.9m $2.4m
Derivative, Gain (Loss) on Derivative, Net $1.1m
Net Cash Provided by (Used in) Operating Activities ($18.5m) ($19.9m) ($28.6m) ($43.6m) ($55.0m) ($83.8m) ($33.1m) $25.9m ($3.6m) $1.0m
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $468k $23k $376k $64k ($267k) ($839k) $727k $8.5m $2.3m $1.2m
Payments to Acquire Investments $13.4m $25.5m $267k $839k
Net Cash Provided by (Used in) Investing Activities ($11.2m) ($71.3m) $27.4m $9.7m $48.2m $55.4m ($19.8m) ($19.9m) ($474k)
Cash flows from financing activities:
Proceeds from Issuance of Common Stock $958k $5.3m $773k $23.5m
Proceeds from the issuance of common stock $958k $5.3m $106.8m $773k $23.5m
Dividends paid $45
Dividends Payable, Current $8
Net Cash Provided by (Used in) Financing Activities $21.1m $111.3m $327k $60.4m $49.6m ($45.0m) $2.5m $2.1m $24.4m
Effect of exchange rate changes on cash and cash equivalents ($1.9m) ($298k) ($273k) $343k
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $11.5m ($15.9m) $15.0m $14.0m ($22.7m) $8.3m ($21.7m) $25.3m
Net increase (decrease) in cash and cash equivalents ($18.8m) $4.2m $11.5m ($15.9m) $15.0m $14.0m ($22.7m) $8.3m ($21.7m) $25.3m
Cash, Cash Equivalents, and Short-term Investments $17.1m $32.4m $120.1m $76.9m $81.9m $46.9m $21.7m $33.5m
Cash and cash equivalents at beginning of the period $19.8m $31.3m $15.4m $30.4m $44.3m $21.7m $33.5m $11.8m $37.1m
Supplemental disclosure of cash flow information:
Income Taxes Paid, Net $6.3m $6.3m $8.5m $5.6m